2020 SPRING VIRTUAL GROUP MEETING
PRESENTATIONS & MATERIALS | May 14-16

For this Group meeting, Alliance meeting sessions and committee meetings will be held virtually. For sessions that are open to all Alliance members, web links and dial-in information are posted on the Alliance member website. For closed meetings, web links and dial-in information will be sent to each specific committee rather than posting these details online. If you have questions, please contact Christina Patel, Alliance Meetings and Events Coordinator, by e-mail capatel@bwh.harvard.edu or phone (617) 525-6543.

Please continue to watch and check this site for meeting and schedule updates.
Also, note that agendas for some meetings/sessions will not be posted.

WELCOME MESSAGE FROM GROUP CHAIR - MONICA M. BERTAGNOLLI, MD (video)

PRINTABLE MEETING SCHEDULE
REGISTER
SOCIAL MEDIA HASHTAG: #AllianceSpring2020

Helpful Guides & Tools | Using Audio/Video Conferencing
Zoom Cheat Sheet - Attendee

AGENDAS
ICARE Working Group/General Info Session | Agenda
TRP Pharmacogenomics and Population Pharmacology Committee | Agenda
Respiratory Committee | Agenda
CRP Information Session | Agenda
Community Oncology Committee | Agenda
Immuno-Oncology Committee | Agenda
Patient Advocate Committee | Agenda
Symptom Intervention Committee | Agenda
CRP Education Session | Agenda
Breast Local Regional Group | Agenda
Health Disparities Committee / Adolescent Young Adult Working Group | Agenda
Cancer in the Older Adult Committee | Agenda
Prevention Committee | Agenda
Myeloma Committee | Agenda

 

2019 FALL GROUP MEETING PRESENTATIONS & MATERIALS / Nov 7-9

SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings 
Note: Agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• Breast Committee
• Cancer in the Older Adult Committee
• Community Oncology Committee
• CRP Education 
• CRP Information
• CRP/Oncology Nursing Open Forum
• CRP Orientation Refresher
• GI Committee
• Health Disparities Committee
• Health Outcomes Committee
• Immuno-Oncology Committee
• Multiple Myeloma Committee
• Patient Advocate Committee
• Pharmacogenomics and Population Pharmacology Committee
• Radiation Oncology Committee
• Respiratory Committee

ePOSTERS
Active Alliance and AFT Trials

• Alliance A011104/ACRIN 6694: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
• Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
• Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Her2 Negative Breast Cancer: The ABC Trial
• Alliance A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
• Alliance A021602: Randomized, Double-blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus
• Alliance A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed By High-dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment Of Germ Cell Tumors (TIGER)
• Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) vs Observation
• Alliance A031701: A Phase II Study of Dose-dense Gemcitabine Plus Cisplatin (ddGC) in Patients with Muscle-invasive Bladder Cancer with
  Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
• Alliance A031702: A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
• Alliance A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
• Alliance A041501: A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL
• Alliance A041701: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
• Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
• Alliance A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Phnegative CD22-positive B-lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
• Alliance A071601: Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
• Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
• Alliance A081105: Randomized Double Blind Observation Controlled Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
• Alliance A091605: A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
• Alliance A091802: Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)
• Alliance A151216: Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
• Alliance A171601: A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-positive, HER2-Negative Metastatic Breast Cancer
• Alliance A211102: Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention versus Placebo Control in Premenopausal Women
• Alliance A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
• Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion Study to Alliance Study A011502
• Alliance A211701: A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort
• POSITIVE (IBCSG 48-14/BIG 8-13/A221405): A Study Evaluating Pregnancy and Disease Outcome and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer Who Desire Pregnancy
• Alliance A221504: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
• Alliance A221505: RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
• Alliance 221602: Olanzapine with or without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo Controlled Trial
• Alliance A221701: Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches
• Alliance A221702: ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence after Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and without Axillary Reverse Mapping
• Alliance A231601CD: Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
• Alliance A231701CD: Increasing Socioeconomically Disadvantaged Patients' Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention (A Limited Access Study)
• CALGB (Alliance) 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
• Alliance N0577 (CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma (CODEL)
• AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study - A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
• AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive Stage IV Non-small Cell Lung Cancer
• AFT-15: A Phase I Study of Ibrutinib (PCI-32765) in Combination with Revlimid/dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma
• AFT-16: Phase II Trial of Induction Immunotherapy with Atezolizumab for Patients with Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy with Curative Intent
• AFT 19: A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
• COMET Study (AFT-25): Comparison of Operative to Monitoring and Endocrine Therapy for Low-risk DCIS
• CANVAS Trial (AFT-28): DOACS versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial
• AFT-32: A Phase II Study of Palbociclib (PD-0322991) in Combination with Ibrutinib in Patients with Previously Treated Mantle Cell Lymphoma
• AFT-38: A Randomized, Open-Label, Phase 3 Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy Versus Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
• PRO-TECT Study (AFT-39): Electronic Patient Reporting of Symptoms During Cancer Treatment
• AFT-42: Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

2019 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 8-11

SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Cancer Care Standards Development
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• Cancer in the Older Adult Committee
• Community Oncology Committee
• CRP Education 
• CRP Information
• CRP Orientation
• Genitourinary Committee
• GI Committee
• Health Disparities Committee
• Health Outcomes Committee
• Immuno-Oncology Committee
• Leukemia Committee
• Lymphoma Committee
• Multiple Myeloma Committee
• Neuro-Oncology Committee
• Patient Advocates Committee
• Radiation Oncology Committee
• Respiratory Committee

AGENDAS: Alliance Foundation Trials (AFT) 
Note: Agendas for some sessions will not be posted.

• AFT Myeloma and Lymphoma Studies
• AFT 25 (COMET)
• AFT 39

PRESENTATIONS: Sessions and Workshops
Note: Presentations for some sessions/workshops will not be posted.

ePOSTERS
Active Alliance and AFT Trials

• Alliance A011104/ACRIN 6694: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
• Alliance A011106: Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
• Alliance A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Receiving Neoadjuvant Chemotherapy
• Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
• Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Her2 Negative Breast Cancer: The ABC Trial
• Alliance A021501: Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
• Alliance A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
• Alliance A021602: Randomized, Double-blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus
• Alliance A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed By High-dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment Of Germ Cell Tumors (TIGER)
• Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) vs Observation
• Alliance A031701: A Phase II Study of Dose-dense Gemcitabine Plus Cisplatin (ddGC) in Patients with Muscle-invasive Bladder Cancer with
  Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
• Alliance A041501: A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL
• Alliance A041701: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
• Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
• Alliance A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Phnegative CD22-positive B-lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
• Alliance A061402: Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy
• Alliance A071601: Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
• Alliance A081105: Randomized Double Blind Observation Controlled Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
• Alliance A091302: Randomized Phase II Study of Sorafenib with or without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer
• Alliance A091605: A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
• Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
• Alliance A171601: A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-positive, HER2-Negative Metastatic Breast Cancer
• Alliance A171603: Feasibility of an Electronic Geriatric Assessment (eGA) for Older Adults with Cancer (A Limited Access Study)
• Alliance A191402CD: Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men (A Limited Access Study)
• Alliance A211102: Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention versus Placebo Control in Premenopausal Women
• Alliance A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
• Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion Study to Alliance Study A011502
• Alliance A211701: A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort
• POSITIVE (IBCSG 48-14/BIG 8-13/A221405): A Study Evaluating Pregnancy and Disease Outcome and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer Who Desire Pregnancy
• Alliance A221504: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
• Alliance A221505: RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
• Alliance 221602: Olanzapine with or without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo Controlled Trial
• Alliance A221701: Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches
• Alliance A231701CD: Increasing Socioeconomically Disadvantaged Patients' Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention (A Limited Access Study)
• CALGB (Alliance) 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
• N0392 (Alliance): Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG Clinical Trials
• Alliance N0577 (CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma (CODEL)
• 2019 Alliance Patient Advocate Committee: Adding Value to the Alliance Clinical Trial Process
• AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study - A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
• AFT-07 (M14-360): A Phase 1 Dose Escalation and Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination with Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects with Stage III Non-Small Cell Lung Cancer (NSCLC)
• AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive Stage IV Non-small Cell Lung Cancer
• AFT-15: A Phase I Study of Ibrutinib (PCI-32765) in Combination with Revlimid/dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma
• AFT-16: Phase II Trial of Induction Immunotherapy with Atezolizumab for Patients with Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy with Curative Intent
• AFT 19: A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
• COMET Study (AFT-25): Comparison of Operative to Monitoring and Endocrine Therapy for Low-risk DCIS
• CANVAS Trial (AFT-28): DOACS versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial
• AFT-32: A Phase II Study of Palbociclib (PD-0322991) in Combination with Ibrutinib in Patients with Previously Treated Mantle Cell Lymphoma
• AFT-38: A Randomized, Open-Label, Phase 3 Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy Versus Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
• PRO-TECT Study (AFT-39): Electronic Patient Reporting of Symptoms During Cancer Treatment
• AFT-42: Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

*          *            *            *              *          *            *            *              *          *

2018 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 1-3

SCHEDULE: Day-to-Day Guide

New Alliance Meeting App Instructions

AGENDAS: Sessions and Committee Meetings 

Note: Agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Cancer Care Standards Development
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• ARM (Axillary Reverse Mapping) Training
• Biorepository Committee
• Breast Committee
• Breast Local Control Group
• Cancer in the Older Adult Committee
• Community Oncology Committee
• CRP Education 
• CRP Information
• Experimental Therapeutics Committee
• Genitourinary Committee
• GI Committee
• Health Outcomes Committee
• Immuno-Oncology Working Group
• Leukemia Committee
• Lymphoma Committee
• Methodology Working Group
• Multiple Myeloma Committee
• Neuro-Oncology Committee
• New Investigator Committee
• Pharmacogenetics and Population Pharmacology Committee
• Prevention Committee
• Radiation Oncology Committee
• Respiratory Committee
• Symptom Intervention Committee
• Transplant Committee

AGENDAS: Alliance Foundation Trials (AFT) 
Note: Agendas for some sessions will not be posted.

• AFT 15
• AFT 19
• AFT 25 (COMET)
• AFT 28
• AFT 29
• AFT 32
• AFT 38 (PATINA)
• AFT 39
• AFT 41
• AFT 42

PRESENTATIONS: Sessions and Workshops

Audit Workshop

Introduction to Alliance Audit

Alliance Audit Regulatory Review

Audit Pharmacy review

Patient Case Records Review

Preparing Your Audit Response

CRP Information Session

Allliance Statistics and Data Center Updates

CTSU Updates

Alliance Administrative and Protocol Office Update

FDA Reg Trials

Preparing Your Audit Response

CRP/Nursing Open Forum

Utilizing a Central Screening Process to Enhance Accrual at a Community NCORP

CRP Education Session

Alliance Protocol Status Sheet

Alliance A021602: CABINET

Implementation of CIRB Requirements

Managing Delegation of Tasks Logs

Lead CRA/Administrator Tips

Lead CRA/Administrator Tips

CRP/Nursing Open Forum

Utilizing a Central Screening Process to Enhance Accrual at a Community NCORP

Boost Your CRP Skills

Boost Your CRP Skills

Note: Presentations for some sessions/workshops will not be posted.

 

*          *            *            *              *          *            *            *              *          *

2018 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 10-12

SCHEDULE: Day-to-Day Guide

Continuing Education (CE) Credit Sessions and Amounts

New Alliance Meeting App Instructions

AGENDAS: Sessions and Committee Meetings 

Note: Agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Cancer Care Standards Development
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• Biorepository Committee
• Breast Committee
• Cancer in the Older Adult Committee
• Community Oncology Committee
• CRP Education 
• CRP Information
• CRP Orientation
• CRP Reception Flyer
• CRP Reception Map
• Experimental Therapeutics Committee
• GI Committee
• Health Disparities Committee
• Health Disparities Education Session
• Health Outcomes Committee
• Leukemia Committee
• Lymphoma Committee
• New Investigator Course
• Pharmacogenetics and Population Pharmacology Committee
• Prevention Committee
• Radiation Oncology Committee
• Respiratory Committee
• Symptom Intervention Committee

AGENDAS: Alliance Foundation Trials (AFT) 
Note: Agendas for some sessions will not be posted.

• AFT 19
• AFT 25 (COMET)
• AFT 28
• AFT 32
• AFT 39
• AFT 41
• AFT 42

PRESENTATIONS: Sessions and Workshops

Note: Presentations for some sessions/workshops will not be posted. Please click on the link above to access all the presentations that we've received. 

 

*          *            *            *              *          *            *            *              *          * 

2017 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 2-4

SCHEDULE: Day-to-Day Guide

Continuing Education (CE) Credit Sessions and Amounts

AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Cancer Care Standards Development
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• Audit Workshop
• Breast Committee
• Biorepository Committee
• Cancer in the Elderly Committee
• Community Oncology Committee
• CRP Education
• CRP Information
• CRP Surgery
• Experimental Therapeutics and Rare Tumor Committee
• Gastrointestinal (GI) Committee
• Health Disparities Committee
• Health Outcomes Committee
• Leukemia/Leukemia Correlative Sciences Committee
• Lymphoma Committee
• Methodology Committee
• Multiple Myeloma Committee
• Neuro-Oncology Committee
• Patient Advocate Committee
• Pharmacogenetics and Population Pharmacology Committee
• Prevention Committee
• Radiation Oncology Committee
• Respiratory Committee
• Symptom Intervention Committee

AGENDAS: Alliance Foundation Trials (AFT) 
Note: Agendas for some sessions will not be posted.

• AFT 09
• AFT 17
• AFT 19
• AFT 25
• AFT 31
• AFT 41
• AFT 42

PRESENTATIONS: Sessions and Workshops
Note: Presentations for some sessions/workshops will not be posted.

• Audit Workshop
  • Welcome and Audit Resources Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
  • Introduction to the Alliance Audit Program Presenter: Scott Okuno, MD, Chair of the Alliance Audit Committee, Mayo Clinic
  • IRB Documentation and Informed Consent Content Presenter: Kurombi Wade-Oliver, CCRP, Alliance Clinical Trials Auditor
  • Patient Case Records Review Presenter: Debra Herzan, RN, OCN, CCRP, Alliance Clinical Trials Auditor
  • Review of Accountability of Investigational Agents and Pharmacy Operations Presenter: Rosalyn Williams, Alliance Clinical Trials Auditor
  • Responding to Audit Findings and Preparing a Corrective Action Plan Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
• Breast Committee
  • Opportunities for QI Tools in Breast Oncology Presenter: Nola Hylton, PhD, UCSF & Maryellen Giger, PhD, University of Chicago
• Clinical Research Professional (CRP) Information Session
  • Alliance Administrative and Protocol Office Update Presenter: Michael Kelly, MA, Director of Protocol Operations
  • Alliance SDC Updates Presenter: Jennifer Darcy, CCRP, Directer, Alliance Statistics and Data Center
  • CTSU Updates Presenter: Martha Hering, Project Manager, CTSU/Westat
  • Importance of Timely Data Submission Presenter: Shauna Hillman, MS, Alliance Statistician 
  • NCI Informed Consent Presenter: Grace Mishkin, MPH, National Cancer Institute 

• Clinical Research Professional (CRP) Information Breakout Sessions
  • It's All About that Rave Presenter: Ryan Potaracke, Alliance SDC
  • RCR Demonstration Presenter: Matthew Boron, PMB, CTEP, National Cancer Institute 
  • The Role of Patient Advocates in Clinical and Translational Research Presenter: Patty Spears, Co-Chair Alliance Patient Advocates Committee

• Clinical Research Professional (CRP) Education Session
  • CTMB Updates Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
  • A021502 Presenter: Frank Sinicrope, MD, Mayo Clinic
  • A021502 (ATOMIC) SAE Integration and Central Monitoring Presenters Shauna Hillman, MS, Alliance Statistician & Martha Hering, Project Manager, CTSU/Westat

• Clinical Research Professional (CRP) Education Breakout Sessions
  • ​AFT Monitoring vs Auditing Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
  • CTSU Reports Presenter: Martha Hering, Project Manager, CTSU/Westat
  • DTL Demonstration Presenter: Matthew Boron, PMB, CTEP, National Cancer Institute 
• Clinical Research Professional (CRP) Surgical Workshop
  • A011104 Presenter: Isabelle Bedrosian, MD, MD Anderson Cancer Center
  • A221208 Presenter: Caroline Chung, MD, MD Anderson Cancer Center
  • Alliance Biorepositories and Biospecimen Resource Presenter: Mark Watson, M.D., Ph.D., Director of Alliance Biorepository
• Imaging Committee
  • The Role of the Experimental Therapeutics and Rare Tumor Committee (ETRTC) in Drug Development Presenter: Gary K. Schwartz, MD, Herbert Irving Comprehensive Cancer Center
• Young Investigators Committee
  • How to Work with Your Statistician Presenter: Fang-Shu Ou, PhD, Faculty Statistician, Alliance Statistics and Data Center

 

PRESENTATIONS: Alliance Foundation Trials (AFT) 
Note: Presentations for some sessions/workshops will not be posted.

• AFT 25 (COMET)

*          *            *            *              *          *            *            *              *          * 

2017 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 10-13

SCHEDULE: Day-to-Day Guide

AGENDAS: Sessions and Committee Meetings
Check back often for updates and additional agendas. Note that agendas for some sessions will not be posted.

• ACS CRP- Cancer Care Delivery Research
• ACS CRP- Cancer Care Standards Development
• ACS CRP- Dissemination and Implementation
• ACS CRP- Education Committee
• Breast Committee
• Cancer in the Elderly Committee
• Community Oncology Committee
• CRP Education Session 
• CRP Information Session
• CRP Orientation 
• Experimental Therapeutics and Rare Tumor Committee
• Gastrointestinal (GI) Committee
• Health Disparities Committee
• Health Disparities Education Session
• Health Outcomes Committee
• Neuro-Oncology Committee
• New Investigator Course
• Nursing and CRP Open Forum
• Patient Advocate Committee
• Pharmacogenetics and Population Pharmacology Committee
• Prevention Committee
• Radiation Oncology Committee
• Respiratory Committee
• Symptom Intervention Committee

PRESENTATIONS: Sessions and Workshops
Check back often for updates and additional presentations. Note that presentations for some sessions/workshops will not be posted.

• Charles G. Moertel Lecture | Plenary Session
  • SOFTly: The Long Natural History of [Trials for] [Premenopausal] ER+ Breast Cancer Presenter: Gini F. Fleming, MD, Director and Principal Investigator, Alliance Central Protocol Operations Program
• Clinical Research Professional (CRP) Orientation
  • Alliance Organizational Structure Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
  • BioSpecimen Management System Presenter: Amy Brink, Washington University School of Medicine 
  • Data Management Presenter: Kristin Honer, Essentia Health 
  • Eligibility Presenter: Jennifer Dill, CCRP, Washington University School of Medicine 
  • Navigating Alliance Protocols Presenter: Morgen Alexander-Young, MPH, Alliance Central Protocol Operations Program
  • RECIST Presenter: Scott Okuno, MD, Audit Committee Chair
• Clinical Research Professional (CRP) Information Session
  • Alliance Administrative & Protocol Office Update, Trini Ajazi, MM, Alliance Chief Administrative Officer
  • CTSU Updates Presenter: Kathi Celii, Project Manager, CTSU
  • Alliance Statistics and Data Center Updates Presenter: Jenny Darcy, CCRP, Directer, Alliance Statistics and Data Center
  • FDA Inspection Overview Presenters: Aimee Farrell, Alliance Senior Project Manager & Jennifer Gaskin, Alliance Director of Quality and Compliance 
  • NCI: Registration and Credential Repository (RCR) & Delegation of Tasks Log (DTL) Presenter: Donna Shriner, RPh, Pharm D, MPH, Senior Clinical Research Pharmacist
• Clinical Research Professional (CRP) Information Breakout Sessions
  • CTSU Projects and Integration Presenter: Kathi Celii, Project Manager, CTSU
  • Making the Job Your Own: Protocol Compliance Workshop Presenters: Tammie Mlodozyniec, CCRP, Essientia Health & Amy Van Hecke, CCRP, Essientia Health 
  • Nursing/CRP Diease Site Presentation: Sarcoma Presenter: Scott Okuno, MD, Audit Committee Chair
• Clinical Research Professional (CRP) Education Session
  • A011502 Presenter: Wendy Chen, MD, MPH, Harvard University 
  • Physician Engagement Presenter: Bret Friday, MD, PhD, Essientia Health
• Clinical Research Professional (CRP) Education Breakout Sessions
  • It's All Grays to Me: Understanding Radiation Data Presenter: Hiram Gay, MD, Washington University School of Medicine
  • A051301 Presenter: Babis Andreadis, MD, MSCE, USCF
• Health Disparities Education Session | Catchment Areas: Engaging our Communities for Improved Outcomes
  • Definition of Catchment Areas Presenter: Electra D. Paskett, PhD, Ohio State University Comprehensive Cancer Center
  • How to Identify Community Partners & Develop Linkages to Enhance Recruitment Presenter: Deborah Erwin, PhD, Roswell Park Cancer Institute
  • Real Life Example: Nueva Vida Intervention Presenters: Kristi Graves, PhD, Georgetown University School of Medicine and Ivis Sampayo, Alliance Patient Advocate
• New Investigator Course
  • NCTN Presenter: Grace Mishkin, MPH, NCTN Operations
  • NCORP Presenter: Worta McCaskill-Stevens, M.D., MS, NCORP Director
  • IROC Presenter: Fran Laurie, BS, Director of Operations, IROC Rhode Island
  • PCORI Presenter: Sarah Daugherty, Ph.D., MPH, Senior Program Officer, Clinical Effectiveness and Decision Science
  • CCDR Presenter: Stephen B. Edge, M.D., FACS, FASCO, Vice President, Healthcare Outcomes and Policy
  • E-PROS Presenter: Lori Minasian, MD, FACP, Deputy Director, Division of Cancer Prevention 
  • Introduction to AFT Presenter: Suzanne George, M.D., Alliance Vice Group Chair
  • Alliance Patient Advocates Presenters: Pat Gavin, RPh, Co-Chair Alliance Patient Advocate Committee & Patty Spears, Co-Chair Alliance Patient Advocate Committee
  • RSS/OPEN/credentialing, cIRB, OEWG Presenter: Michael Kelly, MA, Alliance Director of Protocol Operations
  • Medicare funding sheets, SOC cost issues & working with your EO Presenter: Olwen Hahn, M.D., Former Alliance Executive Officer
  • IND, IDE, International Trials, Registration Trials, & COI  Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
  • Working with your Statistician Presenter: Jennifer Le-Rademacher, PhD, Faculty Statistician, Alliance Statistics and Data Center
  • Forms Development and RAVE Presenter: Shauna Hillman, MS, Statistician 
  • Biospecimens and Biobanking Presenter: Mark Watson, M.D., Ph.D., Director of Alliance Biorepository
  • Contracts Presenter: Angela Klein, Alliance Director of Contracts Management 
  • Clinical Trial Design Presenter: Fang-Shu Ou, PhD, Faculty Statistician, Alliance Statistics and Data Center
  • Study Budget Presenters: Bobby S. Bangura, MBA, Clinical Study Budget Analyst, Alliance Foundation Trials, LLC & Denise Collins-Brennan, Director and Financial Chief Officer, Alliance for Clinical Trials in Oncology 
  • Incorporating Translational Science Presenter Fraser Symmons, M.D., Professor of Pathology, MD Anderson Cancer Center
  • Community Oncology Matters Presenters: Daniel M. Anderson, MD, MPH, Metro-MN Community Oncology Research Consortium, Jon Strasser, MD, Delaware/Christiana Care & Peggy Kemeny, MD, Queens Hospital Center

PRESENTATIONS: Alliance Foundation Trials (AFT)
Check back often for updates and additional presentations. Note that presentations for some sessions/workshops will not be posted.

• AFT-28 CANVAS
  • CANVAS Monthly Newsletter
  • CANVAS Patient Flyer
  • CANVAS Tip Sheet #1
  • CANVAS Tip Sheet #2
  • CANVAS Tip Sheet #3
  • CANVAS Tip Sheet #4

 

*          *            *            *              *          *            *            *              *          * 

2016 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 2-5

SCHEDULE: Day-to-Day Guide

AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.

• Alliance/American College of Surgeons Clinical Research Professional Program (ACS CRP) - Cancer Care Delivery Research Committee
• ACS CRP - Cancer Care Standards Development
• ACS CRP - Dissemination and Implementation Committee
• ACS CRP - Education Committee
• ACS CRP - Executive Committee
• Audit Workshop
• Breast Cancer Surgery
• Cancer Control Program (CCP) - Cancer in the Elderly Committee
• CCP - Community Oncology Committee
• CCP - Health Disparities Committee
• CCP - Health Outcomes Committee  and QoL Methodology
• CCP - Prevention Committee
• CCP - Symptom Intervention Committee
• Clinical Research Professionals (CRP) Education Session
• CRP Information Session
• CRP Orientation Session
• Gastrointestinal (GI) Committee
• Leukemia/Leukemia Correlative Sciences Committee
• Lymphoma Committee
• Patient Advocate Committee
• Radation Oncology Committee
• Respiratory Committee
• Surgical CRP Workshop
• Translational Research Program - Pharmacogenomics and Population Pharmacology Committee

PRESENTATIONS: Sessions and Workshops
Check back often for udpates and additional presentations. Note that presentations for some sessions/workshops will not be posted.

• Audit Workshop
  Welcome to Audit Workshop
  Preparing Your Audit Response: Corrective and Preventative Action Plans (CAPAs)
  Presenter: Barbara Barrett,  MS, CCRP, Alliance Audit Program Director
  Patient Case Records Review
  Presenter: Debra Herzan, RN, OCN, CCRP, Alliance Clinical Trials Auditor
  Introduction to Alliance Audit
  Presenter: Scott Okuno, MD, Audit Committee Chair
  Alliance Audit Regulatory Review
  Presenter: Kurombi Wade-Oliver, CCRP, Alliance Clinical Trials Auditor
  Audit Pharmacy Review
  Presenter: Rosalyn D. Williams, Alliance Clinical Trials Auditor
• New Clinical Research Professional (CRP) Orientation
  RECIST
  Presenter: Scott Okuno, MD, Audit Committee Chair
  Informed Consent
  Presenter: Jim Luecht, CCRP, Inova Schar Cancer Institute, Fairfax VA
  Data Management: Helpful Tips & Common Errors
  Presenter: Kristin Honer, Essentia Health
  Understanding AE Reporting
  Presenter: Peg Reamer, RN, BSN,University of Pittsburgh Department of Cardiothoracic Surgery
  Checking Eligibility: Keys To Successful Patient Enrollment
  Presenter: Katie Dixon
  Navigating Alliance Protocols: Where to Find it and Whom to Contact
  Presenter: Michael Kelly, MA, Director of Protocol Operations
  Alliance Central Protocol Operations Program Update
  Presenter: Michael Kelly, MA, Director of Protocol Operations
• Clinical Research Professional (CRP) Information Session
  Data Management Updates
  Presenter: Jenny Darcy, Alliance Statistics and Data Center
  Clinical Trials Support Unit
  Presenter: Lucille Patrichuk, BSN, MBA
  Your Feedback on Study Result Summaries
  Presenter: Deborah Collyar, Publications Committee
  BioSpecimen Management System-BioMS
  Presenter: Amy Brink, Senior Research Tech, Washington University School of Medicine
  Where We Are: NCI’s Informed Consent Template and Updates to Address Changing Needs
  Presenter: Andrea M. Denicoff, MS, RN, Cancer Therapy Evaluation Program,Division of Cancer Treatment & Diagnosis
• Clinical Research Professional (CRP) Information Breakout Sessions
  Overview of Breast Cancer
  Presenter: Gary W. Unzeitig, MD, FACS
• Clinical Research Professional (CRP) Education Session
  It All Starts Here: Obtaining Informed Consent in the Real World
  Presenters: Betsy Barnick, MHSc, CCRP, Carle Foundation Hospital, Urbana IL and Jim Luecht, CCRP, Inova Schar Cancer Institute, Fairfax VA
• Clinical Research Professional (CRP) Education Breakout Sessions
  MCA Integration into Alliance Clinical Trials
  Presenter: Lisa R. Pitler, JD, MS, RN, University of Illinois at Chicago
  Hematology Malignancies
  Geoffrey L. Uy, MD, Washington University School of Medicine
  Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
  Presenter: Jennifer Ligibel, MD
• Clinical Research Professional (CRP) Surgery Breakout Sessions
  Alliance A211401- Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
  Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD
  Alliance A021501 - Preoperative Chemotherapy and Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
  Presenter: Matthew Katz, MD, FACS
  PROSPECT: Preoperative Radiation or Selective Preoperative Radiation and Evaluation Before Chemotherapy and TME
  Presenter: Deborah Schrag, MD, MPH, Dana-Farber Cancer Institute
• Oncology Nursing Education Sessions
  Immunotherapy, An Exciting Era!!
  Presenter: Yousef Zakharia MD, University of Iowa and Holden Comprehensive Cancer Center
  Managing Immunotherapy Toxicity: The Good, the Bad, and the Ugly
  Presenter: Lisa A. Kottschade  APRN, MSN, CNP, Mayo Clinic-Rochester, MN
• Young Investigators Committee
  Brief Study Chair Guidelines
  Presenter: Gini Fleming, MD

 

*          *            *            *              *          *            *            *              *          * 

2016 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 12-14

SCHEDULE: Day-to-Day Guide
Open Session Teleconference Phone Lines

AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.

• ACS CRP Cancer Care Delivery Research Committee
• ACS CRP Cancer Cancer Standards Development Committee
• ACS CRP Education Committee
• ACS CRP Executive Committee
• Cancer in the Elderly Committee
• Community Oncology Committee
• Clinical Research Professionals (CRP) Education Session
• Clinical Research Professionals (CRP) Information Session
• Experimental Therapeutics Committee
• Gastrointestinal (GI) Committee
• Health Disparities Committee
• Health Outcomes Committee
• Leukemia / Leukemia Correlative Science Committees
• Lymphoma Committee
• Neuro-Oncology Committee
• Oncology Nursing (A-ONC) Education Session
• Pathology Committee
• Patient Advocate Committee (PAC)
• Prevention Committee
• Radiation Oncology Committee
• Symptom Intervention Committee
• Transplant Committee

PRESENTATIONS: Sessions and Workshops
Check back often for udpates and additional presentations. Note that presentations for some sessions/workshops will not be posted.

• Cancer in the Elderly Committee (Cancer Control Program)
  Accrual of Older Breast Cancer Parents to Alliance Systemic Therapy Trials Over Time: Protocol A15127
  Presenter: Rachel Freedman, MD, MPH (Dana-­Farber Cancer Institute)
  The Impact of Full Body Weight-Based Chemotherapy Dosing on Adverse Events and Outcome in Older Breast Cancer Patients: Results from Cancer and Leukemia Group B (CALGB) Trial 49907
  Presenter: Vicki A. Morrison, MD (University of Minnesota)
  Feasibility of an Electronic Geriatric Assessment (eGA) for Older Adults with Cancer
  Study Group: Emily Guerard, MD; Ryan Nipp, MD; Grant Williams, MD; Armin Shahrokni, MD; Jeff Sloan, PhD; Travis Dockter, MS; Arti Hurria, MD; Aminah Jatoi, MD; Harvey Cohen, MD; Hyman Muss, MD
  Identifying Risk Factors For Toxicity in Patients With Hormone Receptor Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study
  Presenter: Daneng Li, MD (City of Hope)
  Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
  Study Team: George J Chang, MD, MS (MD Anderson Cancer Center); Daniel Dohan, PhD (University of California, San Francisco); Amylou Dueck, PhD (Mayo Clinic); Emily Finlayson, MD, MS (University of California, San Francisco); Lisa Lowenstein, PhD, MPH, RD (MD Anderson Cancer Center); Supriya Mohile, MD, MS (University of Rochester)
  Malignant Hematologic Complications Among Older Patients Receiving Adjuvant Anthracycline-­Based Chemotherapy on Modern Cooperative Group Trials
  Presenter: Rachel Freedman, MD, MPH (Dana-­Farber Cancer Institute)
  Musculoskeletal Events in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer (Alliance A171302)
  Study Team: Judith O. Hopkins; Jake Allred; Arti Hurria; Aminah Jatoi; Jacqueline M. Lafky; Harvey Cohen; Cliff Hudis; Eric Winer; Jeanne Mendleblatt; Hyman B. Muss
  Pooled Survival Analysis of First-­line Carboplatin Doublet Chemotherapy for Advanced Non-­small Cell Lung Cancer in Elderly Patients vs. Younger Patients Enrolled in CALGB Trials
  Presenters: Josephine Feliciano; Jared Foster; Ajeet Garja; Aminah Jatoi
  Update on Acute Myeloid Leukemia (AML) Trials in Older Adults
  Presenter: Heidi D. Klepin, MD, MS (Wake Forest School of Medicine)
• Clinical Research Professionals (CRP) Education Session
  Pharmacy and Oral Pill Compliance
  Oral Pill Compliance and Source Documentation
  Presenters: Barbara Barrett, MS, CCRP (Alliance Audit Program Director) and Brenda Gebhart, RPh (Investigational Pharmacist)
  You Have a Study Ready to Open, Now What?
  Presenter: Peg Reamer, RN, BSN
• Clinical Research Professionals (CRP) Information Session
  Site Study Start-Up Requirements for AFT Studies 
  Presenter: Alicia Quirke (Site Manager)
  Where We Are: NCI’s Informed Consent Template and Updates to Address Changing Needs
  Andrea M. Denicoff, MS, RN, Cancer Therapy Evaluation Program, Division of Cancer Treatment & Diagnosis
• Clinical Research Professionals (CRP) Learning Sessions
  CRP Administrator: IPEC Reports
  Presenter, Marcia Kelly (Alliance Membership Manager)
  CRP Administrator/Study Coordinator: Prepping Pharmacy for Audit (Revised)
  What Can You Do Now to Prepare for Pharmacy Audits?
  Presenters: Barbara Barrett, MS, CCRP (Alliance Audit Program Director) and Brenda Gebhart, RPh (Investigational Pharmacist)
  CRP Data Manager: Meet Your Data Manager
  Presenters: Jenny Darcy (Associate Director, Alliance Data Coordination Unit); Julie Moriarity (IT Liaison/Alliance Service Center); Chelsea Schultz (IT Liaison/Alliance Service Center) and Tiffany Schafer (Alliance Data Manager Supervisor)
  CRP Specimen Submission: BioMS Training and Update 2.0
  Presenters: Amy Brink and Mark Watson, Washington University School of Medicine
  CRP Study Coordinator: A01123 (Breast) Study Training
  Presenter: Matthew P. Goetz, MD
  CRP Study Coordinator: A221405 (Breast) Study Training
  CRP Study Coordinator: A221405 (Breast) Study Training (Shortened Version)
  Presenter: Ann H. Partridge, MD, MPH (Dana-Farber Cancer Institue)
  CRP Study Coordinator: A031102 (GU) Study Training
  Presenter: Darren R. Feldman, MD (Memorial Sloan Kettering Cancer Center)
• Community Oncology Committee (Cancer Control Program)
  A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
  Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD
  A Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-­Related Fatigue in Patients with High Grade Glioma
  Presenter: Alyx Porter, MD
  A Randomized Double-Blind Placebo Controlled, Phase II/III, Study of Aromatase Inhibitors and Transdermal Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias: A221102
  Presenters: Stephen Birrell, MD, PhD and Charles Loprinzi, MD
  Alliance A221208: Phase II Randomized Study of Bevacizumab vs. Steroids (BeSt) for Radionecrosis After Radiosurgery for Brain Mets
  Study Co-Chairs: Caroline Chung and Warren Mason
  CALGB 30901: Randomized Phase II Study of Maintenance Pemetrexed vs. Observation for Patients with Malignant Mesothelioma Without Progression After First-­Line Chemotherapy
  Presenter: Arkadiusz Dudek, MD, PhD, FACP
  CCDR Committee Updates
  Presenter: George J Chang, MD MS
  Decision Aids for Prostate Cancer in Minority Men: A191402
  Presenter: Jon Tilburt, MD (Mayo Clinic)
  Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
  Study Team: George J Chang, MD, MS (MD Anderson Cancer Center); Daniel Dohan, PhD (University of California, San Francisco); Amylou Dueck, PhD (Mayo Clinic); Emily Finlayson, MD, MS (University of California, San Francisco); Lisa Lowenstein, PhD, MPH, RD (MD Anderson Cancer
  Center); Supriya Mohile, MD, MS (University of Rochester)
  Mentoring and Development of Young Community Investigators and Research Leaders for the Future
  Presenters: James Bearden, MD and Amy Curtis, MD
  NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131): Interim Analysis Results
  Study Chairs: Keith T. Flaherty; Alice P. Chen; Peter J. O'Dwyer; Barbara A. Conley; Stanley R. Hamilton; Mickey Williams; Robert J. Gray; Shuli Li; Lisa M. McShane; Lawrence V. Rubinstein; Susanna I. Lee; Frank I. Lin; Paolo F. Caimi; Albert A. Nemcek, Jr.; Edith P. Mitchell; James A. Zwiebel
• Health Disparities Committee (Cancer Control Program)
  Decision Aids for Prostate Cancer in Minority Men: A191402
  Presenter: Jon Tilburt, MD (Mayo Clinic)
  Establishing a Cohort of African-American Men to Validate a Method for using Serial PSA Measures to Detect Aggressive Prostate Cancers
  Presenters: James R. Hebert, ScD (University of South Carolina) and Azza Shoaibi, PhD (Medical University of South Carolina)
  Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG / CALGB / NCCTG Trials
  Presenter: Mary Beth Terry, PhD (Mailman School of Public Health)
  Increasing Patient Engagement in Breast Cancer Surgery Decision Making
  Presenter: Heather B. Neuman, MD, MS (University of Wisconsin School of Medicine and Public Health)
  Risk Modeling for Breast-Specific Outcomes, CVD Risk, and Overall Mortality in Alliance Clinical Trials of Breast Cancer
  Presenter: Mary Beth Terry, PhD (Mailman School of Public Health)
  UIC P20–Pilot Research Project Core | Roswell Park Cancer Institute Disparities Updates
• Health Outcomes Committee (Cancer Control Program)
  A201501 Phase II Dignity Therapy / Life Plan in Patients with Pancreatic or Advanced Lung Cancer: Lessons Learned from Concept Submission
  Presenter: Ann Marie Dose, PhD, RN, ACNS-BC, ACHPN (Mayo Clinic)
  A221504: A Randomized, Double-blind, Placebo-controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-small Cell Lung Cancer (Adenocarcinoma)
  Presenter: Pankaj Gupta, MD (Minneapolis VA Health Care System)
  CCDR Committee Updates
  Presenter: George J Chang, MD MS
  Economic Evaluation Service | Kern Center for Science of Healthcare Delivery Mayo Clinic
  Presenter: Bijan J. Borah, PhD (Mayo Clinic College of Medicine)
  Decision Making and Communication about Contralateral Prophylactic Mastectomy
  Presenter: Clara Lee, MD, MPP, FACS (University of North Carolina)
  A Novel Approach to Analyzing Toxicity in Lymphoma Clinical Trials
  Presenter: Gita Thanarajasingam, MD (Mayo Clinic)
  A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
  Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD
• Oncology Nursing (A-ONC) Education
  Chimeric Antigen Receptor T Cell Therapy / CART
  Presenter: Yi Lin, MD, PhD (Mayo Clinic)
• Prevention Committee (Cancer Control Program)
  Data Harmonization & Preliminary Analysis for a Pooling Project of 7 Completed Alliance Trials
  Presenter: Erica Peters, PhD (Battelle Public Health Center for Tobacco Research)
  Optum Labs Overview
  Presenter: Bijan J. Borah, PhD (Mayo Clinic College of Medicine)
   

 

*          *            *            *              *          *            *            *              *          *   

2015 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 5-8

SCHEDULE: Day-to-Day Guide

AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.

• ACS CRP Cancer Care Delivery Research (CCDR) Committee
• ACS CRP Dissemination and Implementation Committee
• ACS CRP Education Committee
• ACS CRP Executive Committee
• Audit Committee
• Breast Committee
• Breast Surgery Meeting
• Cancer in the Elderly Committee
• Community Oncology Committee
  
  Download Important Information About CRP Breakout Sessions (pdf)
  CRP Teleconference Lines (pdf)
  Also note that CRP Information and Education Breakout Sessions are only available for CE credits if they are attended in person. Unfortunately, sessions attended via webinar are not available for CE credit.
• Clinical Research Professionals (CRP) Breakout Session #1
• Clinical Research Professionals (CRP) Breakout Session #2
• Clinical Research Professionals (CRP) Education Session
• Clinical Research Professionals (CRP) Information Session
• Clinical Research Professional (CRP) Surgery Agenda
• Experimental Therapeutics Committee
• Gastrointestinal (GI) Committee
• Genitourinary (GU) Committee
• Health Disparities Committee
• Health Outcomes Committee
• Leukemia/Leukemia Correlative Sciences Committee
• Lymphoma Committee
• Neuro-Oncology Committee
  Alliance Immunotherapy in Neuro-Oncology / Discussion of A071101
  Neuro-Oncology Imaging SubCommittee
• Oncology Nursing Education Session
• Patient Advocate Committee (PAC)
• Pharmacogenomics and Population Pharmacology (PPP) Committee
• Prevention Committee
• Radiation Oncology Committee
• Respiratory Committee
• Symptom Intervention Committee

PRESENTATIONS: Sessions and Workshops

• Audit Preparation
  Audit Pharmacy Review
  Audit Preparation | Introduction to Alliance Audit
  Audit Preparation | Opening Slides
  Audit Preparation | Patient Case Records Review
  Audit Regulatory Review
  Preparing Your Audit Repsonse - Corrective and Preventative Action Plans (CAPAS)
• CRP Breakout
  Making the Job Your Own
  Navigating Multi-Disciplinary Protocols at the Site Level
  Logistics of ALCHEMIST Screening Trial
  Using NCI CIRB
  Alliance A11104 - ACRIN 6694 Effect of Preoperative Breast MRI
  Navigating Studies Under CIRB
  It's All the Rave
  Alliance A041202 Study Review
  Building Relationships with Your Investigators
  CTSU Presentation
  It's Gray to Me
  NCTN-NCORP Funding Info for Sites
  IROC Imaging & Radiation Oncology (updated)
  NCTN-NCORP Navigating Site Codes-MD Registrations
• CRP Information
  CRP Committee As-A-Resource
  Alliance SDC Updates
• CRP Surgery
  Reducing Surgical Complication In Newly Diagnosed Lung Cancer Patients Who Smoke

• Health Disparities
  Overtesting Pros and Cons From Patient Perspective (updated)
  Overtesting in Cancer Staging
  Patient Perspective on Overtesting
• Oncology Nursing
  Alliance Brain Tumor Trials 101: Everything You Wanted to Know and More
  Therapeutic Resistance to Temozolomide and Temozolomide Sensitizing Strategies

 

*          *            *            *              *          *            *            *              *          *   

2015 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 13-16

SCHEDULE: Day-to-Day Guide

AGENDAS: Sessions and Committee Meetings (Note: Agendas will be added as received from committee chairs; agendas for some sessions will not be posted.)

• ACS CRP Cancer Care Delivery Research (CCDR) Committee
• ACS CRP Cancer Care Standards Development (CCSD) Committee
• ACS CRP Education Committee
• Cancer in the Elderly Committee
• CCP Health Disparities Committee
• CCP Health Outcomes Committee
• CCP Prevention Committee
• CCP Symptom Intervention Committee
• Community Oncology Committee
• Clinical Research Professionals (CRP) Education Session
• Clinical Research Professionals (CRP) Information Session
• Experimental Therapeutics Committee
• Gastrointestinal (GI) Committee
• Genitourinary (GU) Committee
• Neuro-Oncology Committee
• Oncology Nursing Education Session
• Patient Advocate Committee
• Pharmacogenomics and Population Pharmacology Committee
• Radiation Oncology Committee
• Respiratory Committee
• Transplant Committee

PRESENTATIONS: Sessions and Workshops

• CRP Education
  ALCHEMIST
  Building Relationships with your Investigators
  CALGB 10403
  Medidata Rave
  RECIST Overview
  Staging Restaging and Response Eval in Lymphomas

• CRP Information
  CTSU Updates
  Medicare Billing
  NCI CIRB
  Pearls of Wisdom Intro
  Pearls of Wisdom Patient Case Review
  Pearls of Wisdom Pharmacy
  Pearls of Wisdom IRB ICC Review
  Strategies for ALCHEMIST Implementation
  Pearls of Wisdom IRB Review
  A031201 Training
  CTSU Website-OPEN

 

*          *            *            *              *          *            *            *              *          *          

 

2014 Fall Group Meeting Presentations & Materials / November 5-8

SCHEDULE: Day-to-Day Guide

Alliance Published Manuscripts

AGENDAS: Sessions and Committee Meetings (Please note: Agendas will be added as they're received from committee chairs; agendas for some sessions will not be posted.)

• Audit Preparation Workshop
• ACS CRP Cancer Care Delivery Research (CCDR)
• ACS CRP Education Session
• ACS CRP Plenary Session
• Breast Committee
• Cancer Control Program (CCP) Executive Committee
• Cancer in the Elderly Committee
• Clinical Research Professionals Education Session
• Clinical Research Professionals Information Session
• Community Oncology Committee
• Experimental Therapeutics Committee
• Gastrointestinal (GI) Committee
• Genitourinary (GU) Committee
• Health Disparities Committee
• Health Outcomes Committee
• Leukemia/Leukemia Correlative Sciences Committee
• Lymphoma Committee
• Neuro-Oncology Committee
• Patient Advocate Committee
• Pathology Committee
• Pharmacogenomics and Population Pharmacology (PPP) Committee
• Pharmacy Committee
• Prevention Committee
• Respiratory Committee
• Surgical Clinical Research Professionals Workshop
• Symptom Intervention Committee

PRESENTATIONS: Sessions and Workshops

• Audit Preparation Workshop (CE Credit)
  Opening Slides
  Alliance Audit Program
  Audit Findings and CAPA
  Drug Accountability and Pharmacy Operations
  IRB Documentation
  Patient Case Review
  PI Perspective
• CRP Education (CE Credit)
  Alliance A071101
  CT AIM MATRIX TOOL
  Substrate Binding by DnaK
  SWOG S1400
• CRP Information (CE Credit)
  ALCHEMIST Update
  CTSU
  Medidate Rave Update
  NCI CIRB
  What is Quality in Research?
  Alliance A11104/ACRIN 6694: Effect of Preoperative Breast MRI onSurgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
  Consolidation of Legacy CALGB Data Management Services to Mayo (non-CE)
• CRP Surgery Workshop Alliance A21102 (CE Credit)
  ALCHEMIST Specimen Submission Logistics (non-CE)
  CRP Surgery Workshop Evaluation Form
• Experimental Therapeutics Committee Presentation
• 14th Annual Jimmie Holland Lecture Series (CE Credit)
  Presented by the Alliance Cancer Control Program
• The Importance of Race in Clinical Trials (CE Credit)
  Presented by the Alliance Health Disparities Committee Education & Training Working Group
  Comparison of Baseline QOL Between Minorities and Non Minority Patients Jeff A. Sloan, MD
  Inclusion of Women Minorities and Children Judith S. Kaur, MD
  Oncology Clinical Research and Race-Statistical Principiles Daniel J. Sargent, PhD
• Oncology Nursing Education Session (CE Credit)
  The Geriatric Oncology Clinic: Similarities and Differences to a Comprehensive Oncology Clinic
• Translational Research Symposium
  Symposium Agenda
  Meaningful Biomarkers in Neoadjuvant Trials Federico Innocenti, MD
  Neoadjuvant Trial of Molecular Therapy for Melanoma Merrick Ross, MD
  Pathologic Response in GI Cancers Jeannelyn S. Estrella, MD
  Pathologic Response in Breast Cancers W. Fraser Symmans, MD
  Perceived Opportunities and Challenges for Neoadjuvant Trials in GI Cancers Alan Venook, MD
   

 

*          *            *            *              *          *            *            *              *          *          

2014 Spring Group Meeting presentations & Materials / May 7-10

SCHEDULE: Day-to-Day Guide

AGENDAS: Sessions and Committee Meetings

• ACS CRP Cancer Care Delivery Research (CCDR)
• ACS CRP Cancer Care Standards Development (CCSD)
• Breast Surgery Group
• Cancer in the Elderly Committee
• Clinical Research Professionals Education Session
• Clinical Research Professionals Informational Session
• Community Oncology Committee
• Experimental Therapeutics Committee
• Gastrointestinal (GI) Committee
• Genitourinary (GU) Committee
• Health Disparities Committee
• Health Outcomes Committee
• Leukemia Committee
• Lymphoma Committee
• Myeloma Commitee
• Neuro-Oncology Committee
• Oncology Nursing Committee
• Patient Advocate Committee
• Pharmacogenomics and Population Pharmacology (PPP) Committee
• Prevention Committee
• Publications Committee
• Radiation Oncology Committee
• Symptom Intervention Committee

PRESENTATIONS: Sessions and Workshops

• CRP Education (CE Credit)
  • Opening Slides for Session
  • Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study (A011106)
  • CALGB 30610: Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
  • CALGB 40903: Phase II Single-Arm Study of Neoadjuvant letrozole for ER(+) Postmenopausal DCIS
• CRP Information (CE Credit)
  • Opening Slides for Session
  • Medicare Coverage for Clinical Trials
  • NCI Cancer Therapy Evaluation Program Adverse Event Reporting System (CTEP-AERS)
  • NCI CIRB Initiative
  • Alliance NCTN Transition Update
• Experimental Therapeutics
  • ETC Presentation
• Oncology Nursing (CE Credit)
  • Opening Slides for Session
  • Role of Statistics in Cancer Research
• Non-CE Credit 
  • Alliance Data Management Updates
  • Alliance Protocol Updates
  • iMedidata Rave Tips
  • Medicare and Clinical Trials
  • Revised CTMB Guidelines